| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/16/2010 | US20100317611 Methods, compositions, unit dosage forms, and kits for pharmacologic stress testing with reduced side effects |
| 12/16/2010 | US20100317610 Methods and Compositions for Inducing Deregulation of EPHA7 and ERK Phosphorylation in Human Acute Leukemias |
| 12/16/2010 | US20100317609 Method of Producing Hydroxyalkyl Starch Derivatives |
| 12/16/2010 | US20100317608 Dithiol Compounds, Derivatives, and Uses Therefor |
| 12/16/2010 | US20100317607 Use of compounds for preparing anti-tuberculosis agents |
| 12/16/2010 | US20100317606 Novel triterpenes for modulating gene expression and cell membrane, and as antiprotozoal agents |
| 12/16/2010 | US20100317605 The use of epimedium flavones and effective components thereof for the preparation of medicaments of promoting proliferations and differentiations of nerve cells |
| 12/16/2010 | US20100317604 Forsythiaside injection preparation and preparative method thereof |
| 12/16/2010 | US20100317603 Treatment of Cancer and Inflammatory Disorder |
| 12/16/2010 | US20100317602 Nutritive compositions and methods of using same |
| 12/16/2010 | US20100317592 Chemokine-binding protein and methods of use |
| 12/16/2010 | US20100317591 Use of lipid conjugates in the treatment of diseases |
| 12/16/2010 | US20100317586 Method for topical treatment of eye disease and composition and device for said treatment |
| 12/16/2010 | US20100317582 Novel cyclic hydrocarbon compounds for the treatment of diseases |
| 12/16/2010 | US20100317580 Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof |
| 12/16/2010 | US20100317576 Methods of enhancing diabetes resolution |
| 12/16/2010 | US20100317575 Pharmaceutical composition comprising a pyrazole-o-glucoside derivative |
| 12/16/2010 | US20100317573 Pediatric fiber mixture |
| 12/16/2010 | US20100317572 Pharmaceutical composition comprising tesofensine or its analogue and an anti-obesity compound |
| 12/16/2010 | US20100317568 Anti-Viral Compounds |
| 12/16/2010 | US20100317566 Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles |
| 12/16/2010 | US20100317563 Methods for modulating the proliferation and differentiation potential of stem cells and progenitor cells |
| 12/16/2010 | US20100317562 Dietary Compositions |
| 12/16/2010 | US20100317519 Mixtures and methods for the induction of resistance in plants |
| 12/16/2010 | US20100317109 Factor |
| 12/16/2010 | US20100317025 Diagnostic Method for Celiac Sprue |
| 12/16/2010 | US20100317003 Novel compositions and methods in cancer with altered expression of kcnj9 |
| 12/16/2010 | US20100316768 Nutritionally Fortified Liquid Composition With Added Value Delivery Systems/Elements/Additives |
| 12/16/2010 | US20100316749 Topical delivery of l-arginine to cause beneficial effects |
| 12/16/2010 | US20100316748 Management and treatment of benign prostatic hyperplasia |
| 12/16/2010 | US20100316745 Use of a cereal extract as a slimming active agent in a slimming cosmetic composition |
| 12/16/2010 | US20100316743 INHIBITION OF THE FORMATION OF AGEs |
| 12/16/2010 | US20100316742 Systems and methods for treating fibromyalgia |
| 12/16/2010 | US20100316731 Treatment of age-related macular degeneration |
| 12/16/2010 | US20100316726 Tooth sealant |
| 12/16/2010 | US20100316725 Reduction of flake-like aggregation in nanoparticulate active agent compositions |
| 12/16/2010 | US20100316723 Compositions and methods for treating inflammation |
| 12/16/2010 | US20100316722 Pharmaceutical Forms for the Release of Active Compounds |
| 12/16/2010 | US20100316721 Granular Sustained Release Preparation and Production Thereof |
| 12/16/2010 | US20100316719 B-1,3-glucan-derived polyaldehyde/polyamine hydrogel |
| 12/16/2010 | US20100316715 Chitosan composition |
| 12/16/2010 | US20100316713 Pharmaceutical composition |
| 12/16/2010 | US20100316712 Pharmaceutical compositions for treatment of parkinson's disease and related disorders |
| 12/16/2010 | US20100316711 Nifedipine containing opress coated tablet and method of preparing same |
| 12/16/2010 | US20100316710 Sustained-release tablet composition of pramipexole |
| 12/16/2010 | US20100316709 Orally disintegrating solid preparation |
| 12/16/2010 | US20100316708 Novel Pharmaceutical Formulation Containing A Biguanide and a Thiazolidinedione Derivative |
| 12/16/2010 | US20100316706 Carbocyclic and oxacarbocyclic fumaric acid oligomers |
| 12/16/2010 | US20100316705 System for exsanguinous metabolic support of an organ or tissue |
| 12/16/2010 | US20100316704 Platinum complexes and methods of use |
| 12/16/2010 | US20100316703 Rna interference mediating small rna molecules |
| 12/16/2010 | US20100316701 Compositions and method for manipulating pim-1 activity in circulatory system cells |
| 12/16/2010 | US20100316699 Compositions and Methods for Inhibiting Viral Replication |
| 12/16/2010 | US20100316697 Methods and compositions for drug targeting |
| 12/16/2010 | US20100316695 Condensation products based on bicyclic or polycyclic aromatics or heteroaromatics |
| 12/16/2010 | US20100316694 Novel filter composites for drug detoxification |
| 12/16/2010 | US20100316691 Biodegradable intravaginal medical device for delivery of therapeutics |
| 12/16/2010 | US20100316682 Biodegradable Hyaluronic Acid Derivative, Biodegradable Polymeric Micelle Composition and Pharmaceutical or Bioactive Composition |
| 12/16/2010 | US20100316681 N-alkylated rifampin |
| 12/16/2010 | US20100316680 Anti-inflammatory properties of marine lipid compositions |
| 12/16/2010 | US20100316679 Compositions for treating or preventing obesity and insulin resistance disorders |
| 12/16/2010 | US20100316678 Combination methods and compositions for treatment of neuropathic pain |
| 12/16/2010 | US20100316677 Use of bamboo leaf total flavones in the preparation of medicine and health food for prevention and treatment of prostatic diseases |
| 12/16/2010 | US20100316676 Bisphosphonate Compounds and Methods for Bone Resorption Diseases, Cancer, Bone Pain, Immune Disorders, and Infectious Diseases |
| 12/16/2010 | US20100316672 Vaccine |
| 12/16/2010 | US20100316659 Immunostimulatory oligoribonucleotides |
| 12/16/2010 | US20100316656 Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use |
| 12/16/2010 | US20100316655 Compounds with mdr1-inverse activity |
| 12/16/2010 | US20100316649 Small molecule inhibitors of spleen tyrosine kinase (syk) |
| 12/16/2010 | US20100316640 Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization |
| 12/16/2010 | US20100316631 Water Soluble Curcumin-Based Compounds |
| 12/16/2010 | US20100316629 Use of gene expression profiling to predict survival in cancer patient |
| 12/16/2010 | US20100316628 Agents and methods for treating respiratory disorders |
| 12/16/2010 | US20100316626 Methods for treatment and diagnosis of psychiatric disorders |
| 12/16/2010 | US20100316624 Treatment of fibroses and liver disorders |
| 12/16/2010 | US20100316622 Diagnosis and treatment of cardiac disorders |
| 12/16/2010 | US20100316616 Use of FZC18-Containing Collagen 18 Polypeptides for the Treatment, Diagnosis and Outcome Prediction of Diseases |
| 12/16/2010 | US20100316615 Antisense Oligonucleotides Against VR1 |
| 12/16/2010 | US20100316609 Conditionally Replicating Viruses for Cancer Therapy |
| 12/16/2010 | US20100316607 Hepatitis c virus inhibitors |
| 12/16/2010 | US20100316605 Inhibitors of phosphatidylinositol 3-kinase |
| 12/16/2010 | US20100316601 Bicyclo-substituted pyrazolon azo derivatives, preparation process and pharmaceutical use thereof |
| 12/16/2010 | US20100316594 Modified 2' and 3' nucleoside prodrugs for treating flaviviridae infections |
| 12/16/2010 | US20100316591 Bioabsorbable polymers |
| 12/16/2010 | US20100316590 Compositions and methods related to poloxamer copolymer membrane sealant |
| 12/16/2010 | US20100316589 Coated Pharmaceutical Compositions |
| 12/16/2010 | US20100316581 Skin External Preparations |
| 12/16/2010 | US20100316575 Modulating body weight |
| 12/16/2010 | US20100316573 Organic Compounds |
| 12/16/2010 | US20100316529 Anti-Microbial Systems and Methods |
| 12/16/2010 | US20100316526 Microwave remediation of medical wastes |
| 12/16/2010 | DE102009025549A1 Zusammensetzung für den Transport von Orotsäure über die Bluthirnschranke Composition for the transport of orotic acid across the blood brain barrier |
| 12/16/2010 | DE102009024732A1 New oligonucleotide, comprising specified nucleotide sequences, is argonaute-1 expression inhibitor, useful for diagnosing or treating disorders or diseases e.g. angiogenesis, hematopoiesis, embryogenesis or tumors e.g. breast cancer |
| 12/16/2010 | DE102009024731A1 New oligonucleotide, comprising specified nucleotide sequences, is argonaute-2 expression inhibitor, useful for diagnosing or treating disorders or diseases e.g. angiogenesis, hematopoiesis, embryogenesis or tumors e.g. breast cancer |
| 12/16/2010 | DE102009024730A1 New oligonucleotide, comprising specified sequences, is argonaute-3a expression inhibitor, useful for diagnosing or treating disorders or diseases e.g. angiogenesis, hematopoiesis, embryogenesis or microRNA-biogenesis |
| 12/16/2010 | DE102009024729A1 New oligonucleotide, comprising specified sequences, is argonaute-4 expression inhibitor, useful for diagnosing or treating disorders or diseases e.g. angiogenesis, hematopoiesis, embryogenesis or microRNA-biogenesis |
| 12/16/2010 | DE102009024542A1 Zusammensetzungen auf Basis von Chitosan-Oligosacchariden Compositions based on chitosan-oligosaccharides |
| 12/16/2010 | CA2847910A1 Anti-viral compounds |
| 12/16/2010 | CA2802334A1 Compositions and methods for imaging tissues, organs and tumors |
| 12/16/2010 | CA2801842A1 Amorphous varenicline tartrate co-precipitates |